Genomic medicine and developing countries: creating a room of their own.
The notion that developing countries must wait for the developed world to make advances in science and technology that they later import at great cost is being challenged. We have previously argued that developing countries can harness human genetic variation to benefit their populations and economies. Based on our empirical studies of large-scale population genotyping projects in Mexico, India and Thailand, we describe how these resources are being adopted to improve public health and create knowledge-based economies. A significant additional benefit is building the capacity for scientific research and internalizing advances in technology, whatever their source.
Séguin
Béatrice
B
McLaughlin-Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario M5G 1L7, Canada.
Hardy
Billie-Jo
BJ
Singer
Peter A
PA
Daar
Abdallah S
AS
D003906:Developing Countries; D014644:Genetic Variation; D005826:Genetics, Medical / Q000639:trends*; D023281:Genomics / Q000379:methods / Q000639:trends*; D016045:Human Genome Project; D006801:Humans; D007194:India; D008800:Mexico; D013785:Thailand